Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Niessen

Showing results (81-90 of 100) with videos related to

Pageof 10
Sort By:
Genes, Chromosomes & Cancer|January 10, 2009
PMS2 involvement in patients suspected of Lynch syndromeRenée C Niessen, Jan H Kleibeuker, Helga Westers, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 28, 2014
Epigenetics in radiotherapy: where are we heading?Kim M Smits, Veerle Melotte, Hanneke E C Niessen, et al.
Genes, Chromosomes & Cancer|April 18, 2009
Do microsatellite instability profiles really differ between colorectal and endometrial tumors?Ana M Ferreira, Helga Westers, Ying Wu, et al.
Journal of Dental Education|March 22, 2001
Report of the ADEA president's task force on the Surgeon General's report on oral health. American Dental Education AssociationP J Ferrillo, K B Chance, R I Garcia, et al.
Oncogene|March 23, 2005
BRAF-V600E is not involved in the colorectal tumorigenesis of HNPCC in patients with functional MLH1 and MSH2 genesEnric Domingo, Renée C Niessen, Carla Oliveira, et al.
The Journal of Pathology|June 13, 2009
Mononucleotide precedes dinucleotide repeat instability during colorectal tumour development in Lynch syndrome patientsAna M Ferreira, Helga Westers, Sónia Sousa, et al.
Plos One|April 9, 2015
MK3 modulation affects BMI1-dependent and independent cell cycle check-pointsPeggy Prickaerts, Hanneke E C Niessen, Vivian E H Dahlmans, et al.
Genes, Chromosomes & Cancer|May 21, 2009
Germline hypermethylation of MLH1 and EPCAM deletions are a frequent cause of Lynch syndromeRenée C Niessen, Robert M W Hofstra, Helga Westers, et al.
Genes, Chromosomes & Cancer|January 22, 2009
Biochemical characterization of MLH3 missense mutations does not reveal an apparent role of MLH3 in Lynch syndromeJianghua Ou, Merete Rasmussen, Helga Westers, et al.
British Journal of Cancer|November 18, 2010
Tumours with loss of MSH6 expression are MSI-H when screened with a pentaplex of five mononucleotide repeatsJ-F You, O Buhard, M J L Ligtenberg, et al.
Pageof 10

Showing results (81-90 of 100) with videos related to

Sort By:
Pageof 10
Genes, Chromosomes & Cancer|January 10, 2009
PMS2 involvement in patients suspected of Lynch syndromeRenée C Niessen, Jan H Kleibeuker, Helga Westers, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 28, 2014
Epigenetics in radiotherapy: where are we heading?Kim M Smits, Veerle Melotte, Hanneke E C Niessen, et al.
Genes, Chromosomes & Cancer|April 18, 2009
Do microsatellite instability profiles really differ between colorectal and endometrial tumors?Ana M Ferreira, Helga Westers, Ying Wu, et al.
Journal of Dental Education|March 22, 2001
Report of the ADEA president's task force on the Surgeon General's report on oral health. American Dental Education AssociationP J Ferrillo, K B Chance, R I Garcia, et al.
Oncogene|March 23, 2005
BRAF-V600E is not involved in the colorectal tumorigenesis of HNPCC in patients with functional MLH1 and MSH2 genesEnric Domingo, Renée C Niessen, Carla Oliveira, et al.
The Journal of Pathology|June 13, 2009
Mononucleotide precedes dinucleotide repeat instability during colorectal tumour development in Lynch syndrome patientsAna M Ferreira, Helga Westers, Sónia Sousa, et al.
Plos One|April 9, 2015
MK3 modulation affects BMI1-dependent and independent cell cycle check-pointsPeggy Prickaerts, Hanneke E C Niessen, Vivian E H Dahlmans, et al.
Genes, Chromosomes & Cancer|May 21, 2009
Germline hypermethylation of MLH1 and EPCAM deletions are a frequent cause of Lynch syndromeRenée C Niessen, Robert M W Hofstra, Helga Westers, et al.
Genes, Chromosomes & Cancer|January 22, 2009
Biochemical characterization of MLH3 missense mutations does not reveal an apparent role of MLH3 in Lynch syndromeJianghua Ou, Merete Rasmussen, Helga Westers, et al.
British Journal of Cancer|November 18, 2010
Tumours with loss of MSH6 expression are MSI-H when screened with a pentaplex of five mononucleotide repeatsJ-F You, O Buhard, M J L Ligtenberg, et al.
Pageof 10